Skip to main content
. 2020 Sep 21;1(3):88–96. doi: 10.14744/hf.2020.2020.0026

Table 1.

Characteristics of the study population

Healthy individuals (no steatosis) (n=85) Healthy individuals (with steatosis) (n=73) NASH (n=101) Total (n=259) p
Age (Y) 42.4±10.3 43.5±9.1 45.0±11.6 44.1±11.3 0.102
Sex [M (%)] 39 (45.8) 36 (49.3) 50 (49.5) 125 (48.2) 0.255
BMI (kg/m2) 24.4±4.3 26.3±6.7 27.1 ±5.3 26.4±5.9 0.091
Laboratory
ALT (U/L) 26.3±11.2 45.4±13.3 55.7±10.0 46.4±12.6 0.022
AST (U/L) 22.0±12.1 37.1 ±15.7 40.6±13.1 38.4±14.5 0.059
GGT (U/L) 55.0±12.4 78.1 ±17.1 91.6±16.4 81.8±15.6 0.034
HOMA-IR 1.9±0.3 2.2±0.9 3.9±1.1 2.8±1.1 0.012
Daily amount of coffee consumption 0.015
None 10 (11.7) 41 (56.2) 76 (75.4) 127 (49.0)
<1 cup 12 (14.2) 6 (8.2) 10 (9.9) 28 (10.9)
1-2 cup 19 (22.4) 13 (17.8) 9 (8.9) 41 (15.9)
3-4 cup 21 (24.7) 9 (12.4) 3 (2.9) 33 (12.6)
>4 cup 23 (27.0) 4 (5.4) 3 (2.9) 30 (11.6)
Duration and amount of coffee consumption 0.028
Occasional coffee drinker 19 (22.4) 13 (17.8) 14 (13.8) 46 (17.8)
Regular coffee drinker (<5 yr) 23 (27.1) 4 (5.4) 6 (5.9) 33 (12.8)
Regular coffee drinker (>5 yr) 33 (38.8) 15 (20.6) 5 (4.9) 53 (20.4)
Alcohol consumption 0.178
None 51 (60.0) 52 (71.2) 101 (100) 204 (78.7)
Mild 29 (34.2) 6 (8.4) 0 35 (13.5)
Moderate 3(3.5) 8 (10.9) 0 11 (4.4)
Heavy 2 (2.3) 7 (9.5) 0 9 (3.42)

NASH: Non-alcoholic steatohepatitis; Y: Year; M: Male; BMI: Body mass index. Results expressed as number (%) or median (range) unless specified otherwise. P-value for comparison of all groups.